Karl Kieburtz
University of Rochester(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, Autism Spectrum Disorder Research, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → The Parkinson Progression Marker Initiative (PPMI)(2011)1,829 cited
- Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial(2000)
- → Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study(2023)630 cited
- → Parkinson's Disease and Movement Disorders(1994)619 cited
- → A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research(2024)501 cited
- → The role of radiotracer imaging in Parkinson disease(2005)372 cited
- → Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial